Current Drug Targets - Cardiovascular & Hematological Disorders

Continued as Cardiovascular & Hematological Disorders-Drug Targets

Personal Subscription

Volume 5 - Issue 6

Editorial: Emerging Pharmacological Strategies for the Prevention of Atherosclerotic Disease Progression promotion: free to download

Volume: 5   Issue: 6
Pp: 431-432
Paul Schoenhagen and Steven E. Nissen
DOI: 10.2174/156800605774962013

Animal Models of Atherosclerosis Progression: Current Concepts

Volume: 5   Issue: 6
Pp: 433-440
A. C. McMahon, L. Kritharides and H. C. Lowe
DOI: 10.2174/156800605774962031

HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol open access plus

Volume: 5   Issue: 6
Pp: 441-453
R. Kleemann and T. Kooistra
DOI: 10.2174/156800605774962077

Cholesterol Absorption Blockade with Ezetimibe

Volume: 5   Issue: 6
Pp: 455-462
Peter P. Toth and Michael H. Davidson
DOI: 10.2174/156800605774962086

Inhibitors of Acyl-Coenzyme A: Cholesterol Acyltransferase

Volume: 5   Issue: 6
Pp: 463-469
Akira Miyazaki, Tomoko Kanome and Takuya Watanabe
DOI: 10.2174/156800605774962040

Peroxisome Proliferator-Activated Receptor ?? (PPAR??) and Atherosclerosis

Volume: 5   Issue: 6
Pp: 513-525
I. Gouni-Berthold and W. Krone
DOI: 10.2174/156800605774962022

Lipoprotein-associated Phospholipase A2: A Potential Therapeutic Target for Atherosclerosis

Volume: 5   Issue: 6
Pp: 527-532
A. Zalewski, C. Macphee and J. J. Nelson
DOI: 10.2174/156800605774962103

Liver X Receptors: Potential Novel Targets in Cardiovascular Diseases

Volume: 5   Issue: 6
Pp: 533-540
Dennis Bruemmer and Ronald E. Law
DOI: 10.2174/156800605774961988